HFrEF
Advertisement
SZC for RAASi Maximization Among Patients With CKD, HFrEF
Charlotte RobinsonWCN 2025 | February 10, 2025
Can SZC help with RAASi maximization without resultant hyperkalemia in patients with HFrEF and CKD?
Read More
Is Sacubitril-Valsartan More Cost Effective than Enalapril for HFrEF?
DocWire News EditorsCardiology | August 21, 2020
Sacubitril-valsartan administration was cost-effective and associated with benefit in patients hospitalized with heart ...
Read More
Cardio Round-up: COVID-19 Updates, Interview, and More
DocWire News EditorsCardiology | April 3, 2020
There is more COVID news in this week's Round-up, including an interview with Dr. Carl J. "Chip" Lavie about some ...
Read More
Dapagliflozin Linked with Reduced Morbidity, Mortality in HFrEF Patients Irrespective of Diabetes
DocWire News EditorsHeart Failure | May 2, 2023
Dapagliflozin reduced cardiovascular morbidity and mortality in patients with heart failure with reduced ejection ...
Read More
Advertisement
Advertisement
Advertisement
Latest News

Reduced-Dose Apixaban Anticoagulation Noninferior to Full Dose in Prevention of Cancer-Associated VTE

April 11, 2025

FDA Approval for Commercial Large-Diameter Thoracic Tapered Implant

April 11, 2025

Do Neuroimaging Gaps Exist in Developmental Disabilities?

April 10, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |